Literature DB >> 20541037

Artesunate, a potential drug for treatment of Babesia infection.

Youn-Kyoung Goo1, M Alaa Terkawi, Honglin Jia, G Oluga Aboge, Hideo Ooka, Bryce Nelson, Suk Kim, Fujiko Sunaga, Kazuhiko Namikawa, Ikuo Igarashi, Yoshifumi Nishikawa, Xuenan Xuan.   

Abstract

The effects of artesunate, a water-soluble artemisinin derivative, against Babesia species, including Babesia bovis, Babesia gibsoni and Babesia microti were studied. Cultures of B. bovis and B. gibsoni were treated with 0.26, 2.6, 26 and 260microM artesunate, showing inhibition of parasite growth at concentrations equal to and greater than 2.6microM artesunate by days 3 post-treatment for B. gibsoni and B. bovis in a dose-dependent manner. Consistent with in vitro experiments, artesunate was effective in the treatment of mice infected with B. microti at doses equal to and greater than 10mg/kg of body weight on days 8-10 post-infection. Taken together, these results suggest that artesunate could be a potential drug against Babesia infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20541037     DOI: 10.1016/j.parint.2010.06.004

Source DB:  PubMed          Journal:  Parasitol Int        ISSN: 1383-5769            Impact factor:   2.230


  19 in total

1.  Timing is everything for artemisinin action.

Authors:  David J Sullivan
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-14       Impact factor: 11.205

2.  Artemisone uptake in Plasmodium falciparum-infected erythrocytes.

Authors:  Sophie Pooley; Farrah A Fatih; Sanjeev Krishna; Michael Gerisch; Richard K Haynes; Ho-Ning Wong; Henry M Staines
Journal:  Antimicrob Agents Chemother       Date:  2010-12-06       Impact factor: 5.191

Review 3.  Artemisinin and its derivatives in treating protozoan infections beyond malaria.

Authors:  Cecilia Shi Ni Loo; Nelson Siu Kei Lam; Deying Yu; Xin-Zhuan Su; Fangli Lu
Journal:  Pharmacol Res       Date:  2016-11-17       Impact factor: 7.658

4.  Artemether Exhibits Amoebicidal Activity against Acanthamoeba castellanii through Inhibition of the Serine Biosynthesis Pathway.

Authors:  Yihong Deng; Wei Ran; Suqin Man; Xueping Li; Hongjian Gao; Wei Tang; Hiroshi Tachibana; Xunjia Cheng
Journal:  Antimicrob Agents Chemother       Date:  2015-05-26       Impact factor: 5.191

5.  Inhibitory effect of cyclophilin A from the hard tick Haemaphysalis longicornis on the growth of Babesia bovis and Babesia bigemina.

Authors:  Hiroki Maeda; Damdinsuren Boldbaatar; Kodai Kusakisako; Remil Linggatong Galay; Kyaw Min Aung; Rika Umemiya-Shirafuji; Masami Mochizuki; Kozo Fujisaki; Tetsuya Tanaka
Journal:  Parasitol Res       Date:  2013-03-27       Impact factor: 2.289

6.  Alsinol, an arylamino alcohol derivative active against Plasmodium, Babesia, Trypanosoma, and Leishmania: past and new outcomes.

Authors:  Maria H Arias; Miguel Quiliano; Sandra Bourgeade-Delmas; Isabelle Fabing; Isabelle Chantal; David Berthier; Cécile Minet; Veronique Eparvier; Jonathan Sorres; Didier Stien; Silvia Galiano; Ignacio Aldana; Alexis Valentin; Giovanny Garavito; Eric Deharo
Journal:  Parasitol Res       Date:  2020-08-08       Impact factor: 2.289

Review 7.  Current advances in detection and treatment of babesiosis.

Authors:  J Mosqueda; A Olvera-Ramirez; G Aguilar-Tipacamu; G J Canto
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

8.  Emergence of babesiosis in China-Myanmar border areas.

Authors:  Xia Zhou; Shang Xia; Shou-Qin Yin; Xiao-Nong Zhou
Journal:  Parasit Vectors       Date:  2015-07-25       Impact factor: 3.876

9.  Diagnosis and management of human babesiosis.

Authors:  Subhash Chandra Parija; Dinoop Kp; Hrudya Venugopal
Journal:  Trop Parasitol       Date:  2015 Jul-Dec

10.  Theileria annae in a young Swedish dog.

Authors:  Ulrika Falkenö; Séverine Tasker; Eva Osterman-Lind; Harold W Tvedten
Journal:  Acta Vet Scand       Date:  2013-07-10       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.